farrerol has been researched along with Mastitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, S; Gong, Q; Guo, W; Kan, X; Li, Y; Liu, J; Ma, H; Xu, D | 1 |
1 other study(ies) available for farrerol and Mastitis
Article | Year |
---|---|
Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chromones; Female; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mastitis; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Peroxidase; Proto-Oncogene Proteins c-akt; Transcription Factor RelA | 2018 |